Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling Hub

Author:

Jung Sung-mokORCID,Loo Sara L.ORCID,Howerton EmilyORCID,Contamin LucieORCID,Smith Claire P.ORCID,Carcelén Erica C.,Yan KatieORCID,Bents Samantha J.,Levander JohnORCID,Espino JessiORCID,Lemaitre Joseph C.ORCID,Sato KojiORCID,McKee Clif D.ORCID,Hill Alison L.ORCID,Chinazzi MatteoORCID,Davis Jessica T.ORCID,Mu KunpengORCID,Vespignani AlessandroORCID,Rosenstrom Erik T.ORCID,Rodriguez-Cartes Sebastian A.ORCID,Ivy Julie S.ORCID,Mayorga Maria E.ORCID,Swann Julie L.ORCID,España GuidoORCID,Cavany SeanORCID,Moore Sean M.ORCID,Perkins AlexORCID,Chen Shi,Paul RajibORCID,Janies DanielORCID,Thill Jean-ClaudeORCID,Srivastava AjiteshORCID,Aawar Majd Al,Bi KaimingORCID,Bandekar Shraddha RamdasORCID,Bouchnita AnassORCID,Fox Spencer J.ORCID,Meyers Lauren AncelORCID,Porebski PrzemyslawORCID,Venkatramanan SriniORCID,Adiga AniruddhaORCID,Hurt Benjamin,Klahn Brian,Outten JosephORCID,Chen JiangzhuoORCID,Mortveit HenningORCID,Wilson Amanda,Hoops StefanORCID,Bhattacharya ParantapaORCID,Machi DustinORCID,Vullikanti Anil,Lewis BryanORCID,Marathe MadhavORCID,Hochheiser HarryORCID,Runge Michael C.ORCID,Shea KatrionaORCID,Truelove ShaunORCID,Viboud CécileORCID,Lessler JustinORCID

Abstract

AbstractImportanceCOVID-19 continues to cause significant hospitalizations and deaths in the United States. Its continued burden and the impact of annually reformulated vaccines remain unclear.ObjectiveTo project COVID-19 hospitalizations and deaths from April 2023–April 2025 under two plausible assumptions about immune escape (20% per year and 50% per year) and three possible CDC recommendations for the use of annually reformulated vaccines (no vaccine recommendation, vaccination for those aged 65+, vaccination for all eligible groups).DesignThe COVID-19 Scenario Modeling Hub solicited projections of COVID-19 hospitalization and deaths between April 15, 2023–April 15, 2025 under six scenarios representing the intersection of considered levels of immune escape and vaccination. State and national projections from eight modeling teams were ensembled to produce projections for each scenario.SettingThe entire United States.ParticipantsNone.ExposureAnnually reformulated vaccines assumed to be 65% effective against strains circulating on June 15 of each year and to become available on September 1. Age and state specific coverage in recommended groups was assumed to match that seen for the first (fall 2021) COVID-19 booster.Main outcomes and measuresEnsemble estimates of weekly and cumulative COVID-19 hospitalizations and deaths. Expected relative and absolute reductions in hospitalizations and deaths due to vaccination over the projection period.ResultsFrom April 15, 2023–April 15, 2025, COVID-19 is projected to cause annual epidemics peaking November–January. In the most pessimistic scenario (high immune escape, no vaccination recommendation), we project 2.1 million (90% PI: 1,438,000–4,270,000) hospitalizations and 209,000 (90% PI: 139,000–461,000) deaths, exceeding pre-pandemic mortality of influenza and pneumonia. In high immune escape scenarios, vaccination of those aged 65+ results in 230,000 (95% CI: 104,000–355,000) fewer hospitalizations and 33,000 (95% CI: 12,000–54,000) fewer deaths, while vaccination of all eligible individuals results in 431,000 (95% CI: 264,000–598,000) fewer hospitalizations and 49,000 (95% CI: 29,000–69,000) fewer deaths.Conclusion and RelevanceCOVID-19 is projected to be a significant public health threat over the coming two years. Broad vaccination has the potential to substantially reduce the burden of this disease.Key pointsQuestionWhat is the likely impact of COVID-19 from April 2023–April 2025 and to what extent can vaccination reduce hospitalizations and deaths?FindingsUnder plausible assumptions about viral evolution and waning immunity, COVID-19 will likely cause annual epidemics peaking in November–January over the two-year projection period. Though significant, hospitalizations and deaths are unlikely to reach levels seen in previous winters. The projected health impacts of COVID-19 are reduced by 10–20% through moderate use of reformulated vaccines.MeaningCOVID-19 is projected to remain a significant public health threat. Annual vaccination can reduce morbidity, mortality, and strain on health systems.

Publisher

Cold Spring Harbor Laboratory

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3